Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12486)
All Articles published online
|
Publishing Process of This Article
|
Sep 28, 2016 (publication date) through Nov 5, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhu JZ, Hollis-Hansen K, Wan XY, Fei SJ, Pang XL, Meng FD, Yu CH, Li YM. Clinical guidelines of non-alcoholic fatty liver disease: A systematic review. World J Gastroenterol 2016; 22(36): 8226-8233 [PMID: 27688665 DOI: 10.3748/wjg.v22.i36.8226] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v22/i36/8226.htm |
| Number | Citing Articles |
| 1 |
Claudio Tana, Cosima Schiavone, Andrea Ticinesi, Fulvio Lauretani, Antonio Nouvenne, Christoph Frank Dietrich, Tiziana Meschi. Hepatic artery resistive index as surrogate marker for fibrosis progression in NAFLD patients: A clinical perspective. International Journal of Immunopathology and Pharmacology 2018; 32 doi: 10.1177/2058738418781373
|
| 2 |
Anja Baumann, Annette Brandt, Ina Bergheim. Fructose, a trigger of metabolic diseases?—a narrative review. Exploration of Digestive Diseases 2022; : 51 doi: 10.37349/edd.2022.00005
|
| 3 |
Rocío Valenzuela-Narváez, Daniel Valenzuela-Narváez. Interaction of periodontal clinical indicators in metabolic syndrome and nonalcoholic fatty liver disease: Implications for preventive interventions. The Saudi Dental Journal 2024; 36(7): 1015 doi: 10.1016/j.sdentj.2024.04.013
|
| 4 |
Naoki Sakane, Kazuhiko Kotani, Akiko Suganuma, Kaoru Takahashi, Juichi Sato, Sadao Suzuki, Kazuo Izumi, Masayuki Kato, Mitsuhiko Noda, Shinsuke Nirengi, Hideshi Kuzuya. Effects of obesity, metabolic syndrome, and non-alcoholic or alcoholic elevated liver enzymes on incidence of diabetes following lifestyle intervention: A subanalysis of the J-DOIT1. Journal of Occupational Health 2020; 62(1) doi: 10.1002/1348-9585.12109
|
| 5 |
Vahid Sheikhi, Zahra Heidari. Low Vitamin D Level was Associated with Non-alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus. Shiraz E-Medical Journal 2021; 23(3) doi: 10.5812/semj.118125
|
| 6 |
Annette Brandt, Cheng Jin, Katja Nolte, Cathrin Sellmann, Anna Engstler, Ina Bergheim. Short-Term Intake of a Fructose-, Fat- and Cholesterol-Rich Diet Causes Hepatic Steatosis in Mice: Effect of Antibiotic Treatment. Nutrients 2017; 9(9): 1013 doi: 10.3390/nu9091013
|
| 7 |
Andressa OLIVEIRA, Sabrina Alves FERNANDES, Randhall Bruce CARTERI, Cristiane Valle TOVO. EVALUATION OF REST ENERGY EXPENDITURE IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE. Arquivos de Gastroenterologia 2021; 58(2): 157 doi: 10.1590/s0004-2803.202100000-27
|
| 8 |
Giulia Besutti, Lisa Bonilauri, Elisa Manicardi, Francesco Venturelli, Efrem Bonelli, Filippo Monelli, Valeria Manicardi, Luca Valenti, Guido Ligabue, Susanna Schianchi, Marco Massari, Nicoletta Riva, Elisabetta Froio, Elena Tagliavini, Pierpaolo Pattacini, Paolo Giorgi Rossi. Feasibility and efficiency of European guidelines for NAFLD assessment in patients with type 2 diabetes: A prospective study. Diabetes Research and Clinical Practice 2021; 177: 108882 doi: 10.1016/j.diabres.2021.108882
|
| 9 |
Kenneth W. Chow, Pragyat Futela, Aryan Saharan, Sammy Saab. Comparison of Guidelines for the Screening, Diagnosis, and Noninvasive Assessment of Nonalcoholic Fatty Liver Disease. Journal of Clinical and Experimental Hepatology 2023; 13(5): 783 doi: 10.1016/j.jceh.2023.01.016
|
| 10 |
Anja Baumann, Cheng Jin, Annette Brandt, Cathrin Sellmann, Anika Nier, Markus Burkard, Sascha Venturelli, Ina Bergheim. Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis. Nutrients 2020; 12(4): 951 doi: 10.3390/nu12040951
|
| 11 |
Alexandra Jichitu, Simona Bungau, Ana Maria Alexandra Stanescu, Cosmin Mihai Vesa, Mirela Marioara Toma, Cristiana Bustea, Stela Iurciuc, Marius Rus, Nicolae Bacalbasa, Camelia Cristina Diaconu. Non-Alcoholic Fatty Liver Disease and Cardiovascular Comorbidities: Pathophysiological Links, Diagnosis, and Therapeutic Management. Diagnostics 2021; 11(4): 689 doi: 10.3390/diagnostics11040689
|
| 12 |
Huanqiu Wang, Ruyu Sun, Sisi Yang, Xueqing Ma, Chengbo Yu. Association between serum ferritin level and the various stages of non-alcoholic fatty liver disease: A systematic review. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.934989
|
| 13 |
Yuqiu Fu, Deyue Zang, Baiyou Lin, Qiming He, Yujie Xie, Baoliang Zhang, Yao Liu, Yi Jin, Yonghong He, Tian Guan. A Deep Learning Method Enables Quantitative and Automatic Measurement of Rat Liver Histology in NAFLD. International Journal of Imaging Systems and Technology 2024; 34(4) doi: 10.1002/ima.23123
|
| 14 |
Mohsen Arabi, Raheleh Alimoradzadeh, Alireza Makian, Seyed Javad Shariat Nabavi, Farshad Divsalar, Mitra Kazemi Jahromi. Non-alcoholic Steatohepatitis Diagnosis and Treatment Medical and Surgery, Based on Guideline Updates: A Mini Review. Journal of Health Reports and Technology 2022; 8(3) doi: 10.5812/jhrt-119454
|
| 15 |
Muhammad Ijaz Ahmad, Xiaoyou Zou, Muhammad Umair Ijaz, Muzahir Hussain, Congcong Liu, Xinglian Xu, Guanghong Zhou, Chunbao Li. Processed Meat Protein Promoted Inflammation and Hepatic Lipogenesis by Upregulating Nrf2/Keap1 Signaling Pathway in Glrx-Deficient Mice. Journal of Agricultural and Food Chemistry 2019; 67(32): 8794 doi: 10.1021/acs.jafc.9b03136
|
| 16 |
Alexa M. Giammarino, He Qiu, Kishen Bulsara, Sabrina Khan, Yu Jiang, Ben L. Da, David E. Bernstein, Sanjaya K. Satapathy. Community Socioeconomic Deprivation Predicts Nonalcoholic Steatohepatitis. Hepatology Communications 2022; 6(3): 550 doi: 10.1002/hep4.1831
|
| 17 |
Mohammed Amin Mohammed, Nesreen Moustafa Omar, Soad Amin Mohammed, Ahmed Mohammed Amin, Doaa Farouk Gad. FICK-3 Score Combining Fibrosis-4, Insulin Resistance and Cytokeratin-18 in Predicting Non-alcoholic Steatohepatitis in NAFLD Egyptian Patients. Pakistan Journal of Biological Sciences 2019; 22(10): 457 doi: 10.3923/pjbs.2019.457.466
|
| 18 |
Carolina M. Perdomo, Nuria Garcia-Fernandez, Javier Escalada. Diabetic Kidney Disease, Cardiovascular Disease and Non-Alcoholic Fatty Liver Disease: A New Triumvirate?. Journal of Clinical Medicine 2021; 10(9): 2040 doi: 10.3390/jcm10092040
|
| 19 |
Kay Craven, Donna Clement, Caroline T. Brewster, Jamie Messenger, Kathryn M. Kolasa. Non-Alcoholic Fatty Liver Disease (NAFLD) and Nutrition. Nutrition Today 2021; 56(6): 296 doi: 10.1097/NT.0000000000000514
|
| 20 |
Leila Zarei, Negin Farhad, Ata Abbasi. All-Trans Retinoic Acid (atRA) effectively improves liver steatosis in a rabbit model of high fat induced liver steatosis. Archives of Physiology and Biochemistry 2022; 128(4): 1010 doi: 10.1080/13813455.2020.1743725
|
| 21 |
Amedeo Lonardo, Simona Leoni, Khalid A. Alswat, Yasser Fouad. History of Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2020; 21(16): 5888 doi: 10.3390/ijms21165888
|
| 22 |
Felipe Galvão Batista Chaves, Glauco Ferreira de Oliveira, João Paulo Ribeiro, João Victor Serafim, Luiz Felipe Medeiros Cordeiro, Matheus Alves Alvares, Marcelo Trindade Cecchi, Murilo Cordeiro Vasquez, Thaísy Bianka Dorta de Souza, Vera Esteves Vagnozzi Rullo. THE THERAPEUTIC IMPACT OF PROBIOTICS ON NONALCOHOLIC FATTY LIVER DISEASE IN PEDIATRICS: A SYSTEMATIC REVIEW. Revista Paulista de Pediatria 2021; 39 doi: 10.1590/1984-0462/2021/39/2019226
|
| 23 |
I.M. Hrytsai, A.Ye. Husieva, V.I. Medved. Obstetric cholestasis: modern recommendations for diagnosis, treatment, management of pregnancy and childbirth . Reproductive health of woman 2022; (4): 11 doi: 10.30841/2708-8731.4.2022.262758
|
| 24 |
Shreya C. Pal, Nahum Méndez-Sánchez. Screening for MAFLD: who, when and how?. Therapeutic Advances in Endocrinology and Metabolism 2023; 14 doi: 10.1177/20420188221145650
|
| 25 |
Fan Li, Gang Sun, Zikai Wang, Wenming Wu, He Guo, Lihua Peng, Lili Wu, Xu Guo, Yunsheng Yang. Characteristics of fecal microbiota in non-alcoholic fatty liver disease patients. Science China Life Sciences 2018; 61(7): 770 doi: 10.1007/s11427-017-9303-9
|
| 26 |
Anika Nier, Anna Janina Engstler, Ina Barbara Maier, Ina Bergheim, Pavel Strnad. Markers of intestinal permeability are already altered in early stages of non-alcoholic fatty liver disease: Studies in children. PLOS ONE 2017; 12(9): e0183282 doi: 10.1371/journal.pone.0183282
|
| 27 |
Paul J. Pockros, Michael Fuchs, Bradley Freilich, Eugene Schiff, Anita Kohli, Eric J. Lawitz, Paul A. Hellstern, Janet Owens‐Grillo, Courtney Van Biene, Reshma Shringarpure, Leigh MacConell, David Shapiro, David E. Cohen. CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patients. Liver International 2019; 39(11): 2082 doi: 10.1111/liv.14209
|
| 28 |
Mengqiu Wei, Jun Liu, Hailin Pan, Ziting Zhou, Kai Guo. Plasma Leukocyte Cell-Derived Chemotaxin 2 (LECT2) as a Risk Factor of Coronary Artery Disease: A Cross-Sectional Study. Angiology 2022; 73(3): 265 doi: 10.1177/00033197211028023
|
| 29 |
Natalia Zhelezniakova, Oleg Babak, Tetiana Aleksandrova. MODERN METHODS OF DIAGNOSIS AND SCREENING OF NON-ALCOHOLIC FATTY LIVER DISEASE AND ITS STAGES: review. Inter Collegas 2022; 8(4): 226 doi: 10.35339/ic.8.4.226-231
|